Pricing & Access· May 18, 2026 · 11 min readJardiance vs Farxiga: label, access, and payer coverage comparedJardiance (empagliflozin) and Farxiga (dapagliflozin) differ on outcomes data, generic status, and 2026 IRA pricing. Compare FDA...By Ran Chen#SGLT2 Inhibitor#Payer Policy#Coverage Access
Pricing & Access· May 17, 2026 · 10 min readFarxiga coverage guide: formulary, prior authorization, and what access teams should knowFarxiga (dapagliflozin) is approved for type 2 diabetes, heart failure, and CKD. Review FDA labels, dosing, 2026 IRA pricing, generic...By Ran Chen#SGLT2 Inhibitor#Formulary#Prior Authorization